StockData
Contineum Therapeutics, Inc. logo

Contineum Therapeutics, Inc. (CTNM) stock

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$9.04−0.20 (-2.16%)

Close on Nov 19, 2026Market cap $340.10MP/E –Yield –

Contineum Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Contineum Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0, down 100.0% year over year. For fiscal 2024 it was $0, down 100.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$0-100.0%
FY2023Dec 31, 2023$50.00M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$0–
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0–
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$0–
Q2 FY2023Jun 30, 2023$50.00M–

More Contineum Therapeutics figures

See a number that looks wrong?